(Q35584811)

9 August 2017

title

Outcomes of research biopsies in phase I clinical trials: the MD anderson cancer center experience (English)

1 reference

9 August 2017

main subject

phase I clinical trial

0 references

10

Razelle Kurzrock

1 reference

Apostolia Maria Tsimberidou

9 August 2017

9

object named as

Apostolia M Tsimberidou

1 reference

9 August 2017

5

Aung Naing

1 reference

9 August 2017

Hazem El-Osta

1

1 reference

9 August 2017

David Hong

2

1 reference

9 August 2017

Jennifer Wheler

3

1 reference

9 August 2017

Siqing Fu

4

1 reference

9 August 2017

Gerald Falchook

6

1 reference

9 August 2017

Marshall Hicks

7

1 reference

9 August 2017

Sijin Wen

8

1 reference

9 August 2017

publication date

22 August 2011

1 reference

9 August 2017

1 reference

9 August 2017

volume

16

1 reference

9 August 2017

issue

9

1 reference

9 August 2017

page(s)

1292-1298

1 reference

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228176

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228176

Ethics of mandatory research biopsy for correlative end points within clinical trials in oncology

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228176

Phase I oncology studies: evidence that in the era of targeted therapies patients on lower doses do not fare worse

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228176

Clinical trial designs for predictive biomarker validation: theoretical considerations and practical challenges.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228176

Communication and informed consent in phase 1 trials: a review of the literature.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228176

Patient motivations surrounding participation in phase I and phase II clinical trials of cancer chemotherapy

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228176

Ethical issues in phase I oncology research: a comparison of investigators and institutional review board chairpersons

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228176

New results will change the paradigm for phase I trials and drug approval

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228176

Equipoise lost: ethics, costs, and the regulation of cancer clinical research.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228176

Dose escalation methods in phase I cancer clinical trials

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228176

Impact and perceptions of mandatory tumor biopsies for correlative studies in clinical trials of novel anticancer agents

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228176

Risks and benefits of phase 1 oncology trials, 1991 through 2002.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228176

Risk factors of pneumothorax and bleeding: multivariate analysis of 660 CT-guided coaxial cutting needle lung biopsies.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228176

Sequential tumor biopsies in early phase clinical trials of anticancer agents for pharmacodynamic evaluation.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228176

Perceptions of cancer patients and their physicians involved in phase I trials

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228176

Are we taking without giving in return? The ethics of research-related biopsies and the benefits of clinical trial participation

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228176

Reduced Mortality Rates Following Elective Percutaneous Liver Biopsies

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228176

Participation in cancer clinical trials: race-, sex-, and age-based disparities

15 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21859821

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Liver biopsy: effects of biopsy needle caliber on bleeding and tissue recovery

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21859821

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Antidepressant-induced bruxism: need for buspirone?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21859821

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1634/THEONCOLOGIST.2011-0043

1 reference

9 August 2017

1 reference

9 August 2017

1 reference